RPTX - Repare Therapeutics GAAP EPS of $0.30 beats by $0.32 revenue of $52.4M beats by $14M
2024-05-07 17:49:11 ET
More on Repare Therapeutics
- Repare Therapeutics appoints Steven Stein to its board of directors
- Repare to regain global rights to camonsertib from Roche
- Seeking Alpha’s Quant Rating on Repare Therapeutics
- Historical earnings data for Repare Therapeutics
- Financial information for Repare Therapeutics